| Literature DB >> 27625644 |
Praveen Rahi1, Om Prakash1, Yogesh S Shouche1.
Abstract
Matrix-assisted laser desorption/ionization time-of-flight mass-spectrometry (MALDI-TOF MS) based biotyping is an emerging technique for high-throughput and rapid microbial identification. Due to its relatively higher accuracy, comprehensive database of clinically important microorganisms and low-cost compared to other microbial identification methods, MALDI-TOF MS has started replacing existing practices prevalent in clinical diagnosis. However, applicability of MALDI-TOF MS in the area of microbial ecology research is still limited mainly due to the lack of data on non-clinical microorganisms. Intense research activities on cultivation of microbial diversity by conventional as well as by innovative and high-throughput methods has substantially increased the number of microbial species known today. This important area of research is in urgent need of rapid and reliable method(s) for characterization and de-replication of microorganisms from various ecosystems. MALDI-TOF MS based characterization, in our opinion, appears to be the most suitable technique for such studies. Reliability of MALDI-TOF MS based identification method depends mainly on accuracy and width of reference databases, which need continuous expansion and improvement. In this review, we propose a common strategy to generate MALDI-TOF MS spectral database and advocated its sharing, and also discuss the role of MALDI-TOF MS based high-throughput microbial identification in microbial ecology studies.Entities:
Keywords: MALDI-TOF mass spectrometry; culturomics; high-throughput identifications; microbial identification; spectral database
Year: 2016 PMID: 27625644 PMCID: PMC5003876 DOI: 10.3389/fmicb.2016.01359
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Comparative studies on identification of microorganisms using different MALDI-TOF MS platforms and databases from the time point of the published work.
| Bacteria from clinical sources (720) | Bruker Biotyper | High confidence identifications (94%) and incorrect identification (0.9%). | Cherkaoui et al., |
| Shimadzu MS with Saramis database | High confidence identifications (89%) and incorrect identification (0.5%). | ||
| Bacteria isolated in routine at hospital (317) | Bruker Biotyper (ver. 2.0) | Correct identification to genus level (97.4%) and species level (94.9%). | Carbonnelle et al., |
| Axima Assurance system Shimadzu/SARAMIS (Anagnos Tec GmbH ver. 2008) | Correct identification to genus level (97.2%) and species level (93.4%). | ||
| Selected bacterial strains with low discrimination with phenotypic tests, unusual antimicrobial susceptibility and fastidious cultures (296) | Bruker Biotyper (ver. 2.0) | Correct identification to genus level (94.9%) and species level (83.4%). | Carbonnelle et al., |
| Axima Assurance system Shimadzu/SARAMIS (Anagnos Tec GmbH ver. 2008) | Correct identification to genus level (83.8%) and species level (65.9%). | ||
| Non-fermenting Gram-negative bacilli isolated from cystic fibrosis (200) | Bruker Biotyper (ver. 3.0) | Overall identification (97%), including species level (72.5%), complex level (5.5%) and genus (19.0%), and no identification (3.0%). | Marko et al., |
| Vitek MS (SARAMIS ver. 3.62) | Overall identification (93%), including species level (80.0%), complex level (3.5%), genus (6.0%) and family (3.5), and no identification (7.0%). | ||
| Bacteria from multiple clinical sources (986) | Bruker Biotyper (ver. 3.0) | Genus and species level (92.7%), genus level (2.8%) and no identification (3.2%). Misidentification to species level (1.2%) and genus level (0%). | Martiny et al., |
| Vitek MS (IVD v1) | Genus and species level (93.2%), genus level (0.4%) and no identification (5.8%). Misidentification to species level (0.4%) and genus level (0.2%). | ||
| Vitek MS (Saramis database) | Genus and species level (83.8%), genus level (3.1%) and no identification (12.8%). Misidentification to species level (0.3%) and genus level (0%). | ||
| Yeasts isolated from routine clinical specimens (312) | Bruker Biflex III-Biotyper (ver. 2.0.4.0) | Valid identification (87.2%), correct species identification of < 1.7 (5.8%), no identification (6.4%) and false species identification (0.6%). | Lohmann et al., |
| Axima-SARAMIS (AnagnosTec ver. 4.07) | Valid identification (82.7%), correct species identification of < 40% (2.9%), no identification (13.1%) and false species identification (1.3%). |
Expansion and creation of reference spectral database to improve MALDI-TOF MS based identification.
| 09 | Columbia agar containing 5% sheep | 8 (32) | 30 | Alispahic et al., | |
| 05 | 8 (32) | 30 | |||
| 03 | 8 (32) | 30 | |||
| Yeast | 109 | SDA medium; incubation time 2–3 d; temperature 30°C. | − | − | Stevenson et al., |
| 56 | YMA and TY media; incubation time 24 h; temperature 28°C. | 12 (36) | 20 | Ferreira et al., | |
| 30 | Fastidious anaerobic agar with 5% horse blood; anaerobic conditions; incubation time 24–48 h; temperature 35°C. | 10 (30) | 20 | Wybo et al., | |
| 09 | BAM and TSA media; anaerobic conditions; incubation time 48–72 h; temperature 28°C. | 20 (20) | 12 | Calderaro et al., | |
| Molds | 294 | SDA medium; incubation time 5 d; temperature 28°C. | − | 10 | Lau et al., |
| 18 | YMA and TY media; incubation time 24, 48, and 72 h; temperature 28°C. | 12 (36) | 20 | Sánchez-Juanes et al., | |
| 04 | BSK-II medium with 6% rabbit serum; incubation time 7 d; temperature 30°C. | 10 (40) | 25 | Calderaro et al., | |
| 20 | EMJH medium; incubation time 7 d; temperature 30°C. | 10 (40) | 25 | Calderaro et al., | |
| Yeast | 156 | SDA medium; incubation time 24–48 h; temperature 35°C. | − | 10 | Carolis et al., |
| 40 | Muller Hinton agar with 5% sheep blood. | 9 (27) | 27 | Murugaiyan et al., | |
| 05 | |||||
| 12 | |||||
| 30 | TSA containing 10% bovine blood; anaerobic conditions; incubation time 2–6 d; temperature 42°C. | 12 (36) | 20 | Warneke et al., | |
| Haloarchaea | 32 | NHA medium. | |||
| Halophilic methanoarchaea | 13 | Defined media with NaCl and trimethylamine. | 24 | 10–24 | Shih et al., |
| Halotolerant and non-halophilic methanoarchaea | 24 | MB/W medium with different methanogensis substrates. |
Replicates per samples spotted on MALDI-TOF MS plate, values in parenthesis are number of spectra generated.
Minimum number of spectra used to create one MSP (main spectra profile).
Figure 1Stepwise strategy to develop highly stringent and authentic database for MALDI-TOF MS based microbial identification.